Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction. Nature Communications , 2023; 14 (1) DOI: 10.1038 ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. ACROBiosystems. (2025, January 17). Activin R for weight loss.

The article, “Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction,” was published in Nature ...

In-Licensing of novel activin E antibody underscores iBio’s commitment to delivering meaningful benefits to patients living with obesity and cardiometabolic diseasesSAN DIEGO, April 22, 2025 ...

The pituitary is the target for and site of synthesis of several growth factors that modulate hormone production and regulate pituitary cell growth. [2] Some growth factors are critical for normal ...

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, in collaboration with AstralBio Inc., announced today the ...

Strong synergistic effect on fat mass (77% reduction) was observed when the Activin E antibody was combined with a GLP-1 receptor agonist, resulting in total weight loss of 35.3%, 7.5% greater ...

Human genetics provide strong evidence for Activin E as a therapeutic target. Individuals with a protective loss-of-function (pLOF) mutation in the INHBE gene have a healthier cardiometabolic profile, ...